Center for Cancer & Blood Disorders
6410 Rockledge Dr #660
Bethesda, Maryland 20817
(301) 571-0019 http://www.ccbdmd.com

Use our guide to learn which trials are right for you!

Widely recognized for its compassionate, expert care, the Center for Cancer and Blood Disorders treats patients throughout the Washington, D.C. area and around the country. Our physicians are Board-certified oncology and hematology specialists who oversee a staff of highly trained physician assistants, nurse practitioners and nurses. Our facilities and technology are the finest available. Our clinical trials are leading the drive toward new options in cancer treatment.

We understand, both professionally and personally, the experience of being diagnosed with a serious disease.We make every effort to schedule your first visit within 48 hours and have designed our treatment centers in Bethesda, Maryland, and Germantown, Maryland, to integrate the best of medical science into an attractive, healing environment that welcomes family participation.

Finally, we subscribe to a wide range of health insurance plans and offer personalized financial counseling so that financial obstacles do not prevent you from receiving appropriate treatment.

We've found
14 trials
at this facility
Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 1/9/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Status: Enrolling, Phase II
Updated: 3/6/2018
mi
from
Bethesda, MD
Click here to add this to my saved trials
Solid Tumors Clinical Trial
MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Advanced Follicular Lymphoma Clinical Trial
An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non-Hodgkin's Lymphoma Clinical Trial
Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients
Status: Enrolling, Phase II
Updated: 6/23/2005
mi
from
Bethesda, MD
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Elotuzumab, Lenalidomide and Dexamethasone (ERd) in the Induction, Consolidation and Maintenance Treatment of Transplant-Eligible, Newly Diagnosed Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials